DD233843A5 - Verfahren zur herstellung neuer heterozylischer verbindungen - Google Patents

Verfahren zur herstellung neuer heterozylischer verbindungen Download PDF

Info

Publication number
DD233843A5
DD233843A5 DD85274834A DD27483485A DD233843A5 DD 233843 A5 DD233843 A5 DD 233843A5 DD 85274834 A DD85274834 A DD 85274834A DD 27483485 A DD27483485 A DD 27483485A DD 233843 A5 DD233843 A5 DD 233843A5
Authority
DD
German Democratic Republic
Prior art keywords
purine
fluorobenzyl
formula
compound
hydrogen
Prior art date
Application number
DD85274834A
Other languages
German (de)
English (en)
Inventor
James L Kelley
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD233843A5 publication Critical patent/DD233843A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD85274834A 1984-04-04 1985-04-03 Verfahren zur herstellung neuer heterozylischer verbindungen DD233843A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848408615A GB8408615D0 (en) 1984-04-04 1984-04-04 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
DD233843A5 true DD233843A5 (de) 1986-03-12

Family

ID=10559131

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85274834A DD233843A5 (de) 1984-04-04 1985-04-03 Verfahren zur herstellung neuer heterozylischer verbindungen

Country Status (14)

Country Link
EP (1) EP0157637A3 (es)
JP (1) JPS60226880A (es)
AU (1) AU4081185A (es)
DD (1) DD233843A5 (es)
DK (1) DK147285A (es)
ES (3) ES8606348A1 (es)
FI (1) FI851351L (es)
GB (1) GB8408615D0 (es)
GR (1) GR850838B (es)
HU (1) HUT37429A (es)
IL (1) IL74803A0 (es)
PL (1) PL252743A1 (es)
ZA (1) ZA852534B (es)
ZW (1) ZW6785A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204353A (en) * 1987-04-07 1993-04-20 Ciba-Geigy Corporation 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith
EP0363320A3 (de) * 1988-10-06 1991-11-21 Ciba-Geigy Ag Substituierte 9H-Purine
US5166209A (en) * 1989-04-21 1992-11-24 Burroughs Wellcome Co. Pharmacologically active compounds
GB8913011D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Anticonvulsant pyrazines
US5240937A (en) * 1990-04-20 1993-08-31 Burroughs Wellcome Co. Pharmaceutically active triazolopyridine compounds
US6992188B1 (en) 1995-12-08 2006-01-31 Pfizer, Inc. Substituted heterocyclic derivatives
DK0778277T3 (da) * 1995-12-08 2003-10-27 Pfizer Substituerede heterocycliske derivater som CRF antagonister
US6107300A (en) * 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
US6648453B2 (en) 1997-07-15 2003-11-18 Silverbrook Research Pty Ltd Ink jet printhead chip with predetermined micro-electromechanical systems height
WO2022011171A1 (en) * 2020-07-08 2022-01-13 Klotho Therapeutics, Inc. Novel compounds and methods for increasing klotho gene expression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846426A (en) * 1971-03-03 1974-11-05 Int Minerals & Chem Corp 6-amino-9-(substituted benzyl) purines and their n{11 oxides
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
GB1547214A (en) * 1977-08-09 1979-06-06 Merck & Co Inc Purine derivatives
US4189485A (en) * 1977-08-23 1980-02-19 Takeda Chemical Industries, Ltd. Purine derivatives
US4900826A (en) * 1981-09-24 1990-02-13 Kohjin Co., Ltd. Process for preparing N6,9-disubstituted adenine

Also Published As

Publication number Publication date
ES8802052A1 (es) 1987-03-01
FI851351A0 (fi) 1985-04-03
EP0157637A3 (en) 1986-11-05
ES8606348A1 (es) 1986-04-16
FI851351L (fi) 1985-10-05
GR850838B (es) 1985-11-25
HUT37429A (en) 1985-12-28
ES550467A0 (es) 1987-03-01
ES550466A0 (es) 1987-03-01
ZW6785A1 (en) 1986-11-12
DK147285D0 (da) 1985-04-01
ZA852534B (en) 1986-11-26
ES541948A0 (es) 1986-04-16
ES8802051A1 (es) 1987-03-01
EP0157637A2 (en) 1985-10-09
JPS60226880A (ja) 1985-11-12
PL252743A1 (en) 1986-09-09
AU4081185A (en) 1985-10-10
GB8408615D0 (en) 1984-05-16
DK147285A (da) 1985-10-05
IL74803A0 (en) 1985-07-31

Similar Documents

Publication Publication Date Title
DE68929554T2 (de) Piperazinyl-substituierte Phenylpyrimidinderivative zur Behandlung oder Vorbeugung von ZNS Erkrankungen
DE69815378T2 (de) Adenosin a1-rezeptor agonisten
DE69817611T2 (de) 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
EP0682027B1 (de) Pyrrolopyrimidinderivate mit antiproliferativer Wirkung
DE1620649A1 (de) Verfahren zur Herstellung neuer Hydroxypyrimidine
CH629206A5 (de) Verfahren zur herstellung neuer substituierter purine.
DD284679A5 (de) Verfahren zur herstellung von adenosin 5'-carboamidderivate
DD203052A5 (de) Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxy-methyl)-guanin, dessen salzen und bestimmten benzylderivaten desselben
WO1993016091A1 (de) Neue liponucleotide, deren herstellung sowie deren verwendung als antivirale arzneimittel
DD201896A5 (de) Verfahren zur herstellung neuer in 5-position substituierter 2,4-diamino-pyrimidine
DD151309A5 (de) Verfahren zur herstellung von substituierten aminotriazinen
DD273833A5 (de) N 9 - cyclopentylsubstituierte adeninderivate
EP0005205A1 (de) Substituierte 5,6-Dimethylpyrrolo(2,3-d)pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE19744027A1 (de) Substituierte Pyrazolo[3,4-b]pyridine, ihre Herstellung und Verwendung in Arzneimitteln
DD233843A5 (de) Verfahren zur herstellung neuer heterozylischer verbindungen
DE2056327A1 (de) Aminopunn Derivate
DD297819A5 (de) Verfahren zur herstellung von 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidinderivaten
DE3390162T1 (de) Desoxyuridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
EP0317855B1 (de) Pharmazeutische Präparate
DE2512609A1 (de) Pharmazeutische zubereitung
DE3786256T2 (de) Antifolat-mittel.
EP0621037A1 (de) Pyrido-pyrimidindione, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3872028T2 (de) Therapeutische nucleoside.
DE2156637A1 (de) Purinzuckerderivate, Verfahren zu ihrer Herstellung und ihrer Verwendung
DE2921844C2 (de) 1-(2-Chlorethyl)-1-nitroso-3-substituierte-3-glycosylharnstoffe, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen